Go to content

Orion

Feb 23rd 2012
  • Suomeksi
  • Text size
  •  Home 
  • Orion
  •  Products and services 
  •  Research and development 
  •  News and media 
  •  Investors 
  •  Sustainability 
  • Careers
  • Orion in brief
  • Business environment
  • Business Divisions
    • Proprietary Products
    • Specialty Products
    • Animal Health
    • Fermion
      • APIs
      • About Fermion
      • CRAMS
      • Contacts
    • Orion Diagnostica
  • Line functions
  • Operational model
  • Partnering / Licensing
  • Strategy
  • Corporate Governance
  • General Meetings of Shareholders
  • History
  • Values
  • Orion Events Calendar
Home / Orion / Business Divisions / Fermion / CRAMS
Print

CRAMS

 

  • CRAMS@Fermion 

  • CRAMS Business Processes

  • Overview of Services Offered

  • Discovery and Preclinical Phases

  • Development activities in Clinical Phases

  • Manufacturing of dosage forms

  • Finished Dosage Forms Capabilities

  • Evaluation of in-licensing opportunities

  • Product concepts during scale-up

  • Partner networks

  • Oncology/High Potent Compounds

  • Technology available

  • Patents and Publications

  • Confidentiality

  

 

 

  

 


 

Updated Nov 24th 2011
 
Contact Fermion: CRAMS@orion.fi

For enquiries in the US:


SST Corporation
435 Brighton Road 07012 CLIFTON, NJ
www.sst-corp.com
Phone: +1 973 473 4300




For enquiries in Japan:


e-mail: info@chukan.co.jp
www.chukan.co.jp
Phone: 06-6231-5127
Fax: 06-6222-5126

 

 
Orion Corporation, Orionintie 1A, 02200 Espoo, PO Box 65, FI-02101 Espoo, Finland
Phone +358 104261 © Copyright Orion Corporation. Company code, VAT 19992126,
  • Contacts
  • About this website
  • Disclaimer
  • Sitemap
  • Feedback form